Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses.
Stroke induces a systemic response that involves rapid activation of inflammatory cascades, followed later by immunodepression. Experimental stroke-induced responses in the bone marrow, which is the primary source of circulating monocytes and granulocytes, have not been investigated previously. We show that cerebral ischaemia induced early (4  hours) release of CXCR2-positive granulocytes from the bone marrow, which was associated with rapid systemic upregulation of CXCL1 (a ligand for CXCR2) and granulocyte-colony-stimulating factor, a key cytokine involved in the mobilisation of bone marrow leukocytes. This process involves rapid activation of nuclear factor-κB and p38 mitogen-activated protein kinase in bone marrow myeloid cells. T-cell numbers in the bone marrow increased after stroke, and bone marrow cells did not show suppressed cytokine response to bacterial endotoxin stimulation in vitro. Stroke-induced laterality observed in the brain stem and in the bone marrow indicates direct involvement of the autonomic nervous system in stroke-induced cell mobilisation. We also show that systemic inflammatory changes and leukocyte responses in the bone marrow are profoundly affected by both anaesthetic and surgical stress. We conclude that stroke influences leukocyte responses in the bone marrow through multiple mechanisms and suggest that preclinical studies should take into consideration the effect of surgical manipulation in experimental models of stroke.
Faculty of Life Sciences, University of Manchester, Manchester, UK. adam.denes@manchester.ac.uk
Adam
A
Denes
Barry W
BW
McColl
Sophie F
SF
Leow-Dyke
Katie Z
KZ
Chapman
Neil E
NE
Humphreys
Richard K
RK
Grencis
Stuart M
SM
Allan
Nancy J
NJ
Rothwell
D000818:Animals; D015153:Blotting, Western; D001853:Bone Marrow / Q000473:pathology*; D001854:Bone Marrow Cells / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D004731:Endotoxins / Q000633:toxicity; D005434:Flow Cytometry; D007839:Functional Laterality / Q000502:physiology; D006098:Granulocytes / Q000378:metabolism; D007150:Immunohistochemistry; D020244:Infarction, Middle Cerebral Artery / Q000473:pathology; D007249:Inflammation / Q000473:pathology; D007694:Killer Cells, Natural / Q000502:physiology; D007962:Leukocytes / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D022423:Myeloid Cells / Q000502:physiology; D016328:NF-kappa B / Q000378:metabolism; D023063:Receptors, Interleukin-8B / Q000378:metabolism; D020521:Stroke / Q000473:pathology*; D013601:T-Lymphocytes / Q000502:physiology
D016207:Cytokines; D004731:Endotoxins; D016328:NF-kappa B; D023063:Receptors, Interleukin-8B